Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jan 29;5(1):e61. doi: 10.1038/cti.2015.40

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2016 Australasian Society for Immunology Inc.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

Lymphoma samples were tested for the expression of Tenth Human Leukocyte Differentiation Antigen (HLDA10) monoclonal antibodies (mAbs) by immunohistochemistry of paraffin sections. (a) mAb to CD1a (10-03) on reactive lymph nodes and (b) lymph nodes involved with Hodgkin lymphoma (HL). (c) mAb to LPAP (10-04) on lymphomas and reactive lymph nodes. (d) LPAP (10-19) did not stain the Reed–Sternberg cells in HL (arrow). (e) The 10-04 mAb did not stain non-lymphoid cells in the liver tissue. (f) LPAP (10-19) weakly stained all lymphoid cells in lymphomas. (g) FAT1 cadherin (10-16) on reactive lymph node specimens. (h) Calreticulin (10-23) on reactive lymph nodes and (i) showing increased staining intensity in Reed–Sternberg cells in HL and (j) scattered large cells in HL and follicular lymphoma (FL). (k) The IL-13-Ra2 (10-37) mAb on HL and (l) on reactive lymph nodes.